View Single Post
Old 06-23-2022, 06:34 PM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,936
Study finds a more effective treatment option for HER2 mutant metastatic breast cance

Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable.

More...
News is offline   Reply With Quote